GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » APT Medical Inc (SHSE:688617) » Definitions » Research & Development

APT Medical (SHSE:688617) Research & Development : ¥251 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is APT Medical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. APT Medical's Research & Development for the three months ended in Mar. 2024 was ¥66 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥251 Mil.


APT Medical Research & Development Historical Data

The historical data trend for APT Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

APT Medical Research & Development Chart

APT Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 70.42 71.90 134.88 174.88 237.92

APT Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.61 56.32 59.39 69.60 65.62

APT Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥251 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


APT Medical  (SHSE:688617) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


APT Medical Research & Development Related Terms

Thank you for viewing the detailed overview of APT Medical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


APT Medical (SHSE:688617) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
Executives
Dai Zhen Hua Directors, senior managers
Cheng Zheng Hui Directors, senior managers
Zhang Yong Core technical personnel
Liu Fang Yuan senior management
Wang Wei senior management
Senior management, core technical personnel
Xu Yi Qing Directors, senior managers
Han Yong Gui Senior management, core technical personnel

APT Medical (SHSE:688617) Headlines

No Headlines